Exelixis EXEL Business Segments — Interest Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's business segments — interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's business segments — interest income?
- Exelixis (EXEL) reported business segments — interest income of $16.13M in Q1 2026.
- How has Exelixis's business segments — interest income changed year-over-year?
- Exelixis's business segments — interest income decreased by 15.5% year-over-year, from $19.08M to $16.13M.
- What is the long-term trend for Exelixis's business segments — interest income?
- Over 3 years (2022 to 2025), Exelixis's business segments — interest income has grown at a 27.9% compound annual growth rate (CAGR), from $33.07M to $69.21M.
- What does business segments — interest income mean?
- Earnings generated from the company's cash reserves and investments.
- How do you interpret business segments — interest income?
- Higher interest income reflects a strong cash position and effective treasury management in a favorable interest rate environment.
- How does business segments — interest income compare across companies?
- Standard interest income metric; comparable to 'Interest and Investment Income' at other cash-rich biotech firms.